RxSight, Inc. (RXST) stock
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3075% below fair value
$4.61−0.40 (-7.98%)
Close on Nov 19, 2026Market cap $191.75MP/E –Yield –
RxSight gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
RxSight's gross profit for the twelve months ending Jun 30, 2026 was $98.87M, down 8.0% year over year. For fiscal 2025 it was $103.01M, up 4.1% from the year before. The highest annual figure on record is $103.01M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.01M | +4.1% |
| FY2024 | Dec 31, 2024 | $98.94M | +84.0% |
| FY2023 | Dec 31, 2023 | $53.77M | +152.1% |
| FY2022 | Dec 31, 2022 | $21.33M | +372.2% |
| FY2021 | Dec 31, 2021 | $4.52M | +164.9% |
| FY2020 | Dec 31, 2020 | $1.71M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $25.89M | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | $23.50M | -17.1% |
| Q4 FY2025 | Dec 31, 2025 | $25.26M | -12.2% |
| Q3 FY2025 | Sep 30, 2025 | $24.23M | -3.9% |
| Q2 FY2025 | Jun 30, 2025 | $25.19M | +3.9% |
| Q1 FY2025 | Mar 31, 2025 | $28.33M | +37.0% |
| Q4 FY2024 | Dec 31, 2024 | $28.79M | +63.1% |
| Q3 FY2024 | Sep 30, 2024 | $25.22M | +83.7% |
| Q2 FY2024 | Jun 30, 2024 | $24.25M | +101.8% |
| Q1 FY2024 | Mar 31, 2024 | $20.69M | +99.5% |
| Q4 FY2023 | Dec 31, 2023 | $17.65M | +137.9% |
| Q3 FY2023 | Sep 30, 2023 | $13.73M | +156.4% |
| Q2 FY2023 | Jun 30, 2023 | $12.02M | +150.9% |
| Q1 FY2023 | Mar 31, 2023 | $10.37M | +175.6% |
| Q4 FY2022 | Dec 31, 2022 | $7.42M | +158.7% |
| Q3 FY2022 | Sep 30, 2022 | $5.36M | +299.4% |
| Q2 FY2022 | Jun 30, 2022 | $4.79M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.76M | +236.1% |
| Q4 FY2021 | Dec 31, 2021 | $2.87M | +107.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.34M | +86.3% |
| Q2 FY2021 | Jun 30, 2021 | -$812.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $1.12M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.38M | – |
| Q3 FY2020 | Sep 30, 2020 | $720.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$474.00K | – |
See a number that looks wrong?